Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis
M Hasselblatt, C Thomas, V Hovestadt, D Schrimpf… - Acta …, 2016 - Springer
Revised: 29 March 2016/Accepted: 1 April 2016/Published online: 11 April 2016© Springer-
Verlag Berlin Heidelberg 2016 showing cytological atypia, increased mitotic activity …
Verlag Berlin Heidelberg 2016 showing cytological atypia, increased mitotic activity …
Prognostic and therapeutic markers in chordomas: a study of 287 tumors
A Tauziède-Espariat, D Bresson… - … of Neuropathology & …, 2016 - academic.oup.com
Chordomas are slow-growing malignant neoplasms. Determination of histopathologic
prognostic factors using a large cohort study has been limited by their low incidence. In this …
prognostic factors using a large cohort study has been limited by their low incidence. In this …
Primary bone tumors of the skull: spectrum of 125 cases, with review of literature
Aims Primary skull bone tumors, benign or malignant, are rare, and include a vast repertoire
of lesions. These tumors are not reported systematically in the literature, with most studies …
of lesions. These tumors are not reported systematically in the literature, with most studies …
Secondary EWSR1 gene abnormalities in SMARCB1‐deficient tumors with 22q11‐12 regional deletions: Potential pitfalls in interpreting EWSR1 FISH results
SMARCB1 inactivation occurs in a variety of tumors, being caused by various genetic
mechanisms. Since SMARCB1 and EWSR1 genes are located close to each other on …
mechanisms. Since SMARCB1 and EWSR1 genes are located close to each other on …
Congenital brain tumors
I Nikas, M Themistocleous, I Vraka… - Journal of Pediatric …, 2016 - thieme-connect.com
Congenital brain tumors, unlike those of older children and adults, are a rare entity,
accounting for less than 2% in terms of incidence, of all childhood brain tumors. They differ …
accounting for less than 2% in terms of incidence, of all childhood brain tumors. They differ …